InVivo Therapeutics Holdings buy BiotechBee
Start price
10.01.23
/
50%
€2.16
Target price
31.12.25
€4.00
Performance (%)
-46.57%
End price
05.05.23
€1.15
Summary
This prediction ended on 05.05.23 with a price of €1.15. The BUY prediction by BiotechBee for InVivo Therapeutics Holdings performed very badly with a performance of -46.57%. BiotechBee has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
InVivo Therapeutics Holdings | - | - | - |
iShares Core DAX® | 1.518% | 3.456% | 25.970% |
iShares Nasdaq 100 | 1.240% | 2.983% | 31.325% |
iShares Nikkei 225® | 2.808% | 2.743% | 19.597% |
iShares S&P 500 | 0.403% | 2.187% | 28.624% |
According to BiotechBee what are the pros and cons of InVivo Therapeutics Holdings for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Invivo Therapeutics diskutieren
Buy mit Kursziel 4,0
In the thread Trading InVivo Therapeutics Holdings
Buy beendet